We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Diane Paskiet, Director, Scientific Affairs, serves as co-chair for the 2014 PDA Packaging Conference: Pharmaceutical Packaging Systems – Current and Emerging Practices, Technologies and Materials, which will be held at the Washington Marriott Wardman Park, Washington, D.C. on May 20-21, 2014.
This year’s conference focuses on the current and future challenges for parenteral packaging across a wide range of topics, including FDA regulatory thought on packaging standards and container closures, customer/supplier issues, quality agreements, innovations in packaging and reducing the complexity of the drug manufacturing process.
Diane will moderate “Pharmaceutical packaging Systems: An FDA Perspective on Quality and Risk Management” on Tuesday, May 20 from 8:30-10:00 a.m. and “Understanding Container Closure Systems and Potential Risks to Pharmaceutical Quality” on Wednesday, May 21 from 8:30-10:00 a.m.
West is proud to announce that Diane Paskiet, Director, Scientific Affairs will serve as Co-chair at the upcoming PDA Packaging Conference in Baltimore, MD. In her leadership role for the meeting, Diane will moderate several sessions, including <em>Repackaging – Problems and Solutions</em> and <em>The Future Direction of Devices and Patient Adherence/Compliance</em>.
Diane Paskiet, Director, Scientific Affairs, will present at two sessions during the <strong>2012 PDA Annual Meeting. The meeting will be held from April 16-18, 2012 at the JW Marriott Desert Ridge Resort in Phoenix, Arizona.</strong>
In aseptic pharmaceutical manufacturing, the packaging for parenteral packaging components is essential for ensuring proper sterilization and utilization. The importance cannot be overstated. Ineffective component packaging can potentially affect patient safety, and result in significant financial loss. Acknowledging this, West conducts exhaustive testing on its packaging systems to ensure that quality and functionality requirements are achieved.
In recent years, there has been a shift in the pharmaceutical industry toward a Quality by Design (QbD) philosophy. To maximize a drug product’s safety and efficacy, pharmaceutical companies and their drug packaging and delivery partners are building new quality principles into the entire manufacturing process, from design and development to commercialization and administration. This scientific, risk-based QbD approach is fast becoming an essential strategy for bringing high-quality therapeutics to market quickly and efficiently.
In <a href="/blog/2017/june/packaging-supplier-regulatory-support-part-2">Part 2</a> of this series, we discussed the importance of choosing a packaging component supplier with a global focus. In this post, we’ll address the need for a supplier to understand and align with your drivers.
English
Chinese
